Renal Cell Carcinoma Module
| ORDER ASSESSMENT TOOLS |
MD Anderson Symptom Inventory (MDASI) modules augment the 19 core MDASI symptom and interference items with additional items identified as unique to a particular patient population. MDASI modules may be disease-specific, disease-site-specific, or treatment-specific.
The MDASI-RCC is a disease-specific module. Along with the core MDASI’s 13 symptom items and 6 interference items, the MDASI-RCC also assesses 4 symptoms specific to renal cell carcinoma:
- rash or skin change
- headache
- mouth or throat sores
- diarrhea
The MDASI-RCC is under development. It is available for licensing, but it has not been psychometrically validated.
MDASI-RCC Features
- Purpose: To assess the severity of multiple symptoms related to renal cell carcinoma and the impact of these symptoms on daily functioning
- Population: Patients with symptoms caused by renal cell carcinoma and its treatment
- Assessment areas: Severity of multiple symptoms and the impact of symptoms on daily functioning during the last 24 hours
- Method: Self-report; paper-and-pencil form or tablet PC (self-administered or via interview), or telephone-based interactive voice response (IVR) system
- Time required: Five minutes
- Scoring: Please see the MDASI User's Guide
- Reliability: Cronbach alpha reliability ranges from 0.88 to 0.91
MDASI-RCC Language Versions
The MDASI-RCC is available in the languages shown below. Click on a linked language to view a sample in PDF format.
| Psychometrically and Linguistically Validated | Linguistically Validated |
|---|---|
| English |
Future Validation Studies: We would like to collaborate with other investigators to develop and validate new language versions of the MDASI-RCC. Contact us for more information. NOTE: The MDASI-RCC may not be modified or translated into another language without express written consent (see Notice of Copyright below).
To Order the MDASI-RCC
To use the MDASI-CLL in a publication or clinical or research trial, you must obtain permission by filling out our order form and you must comply with the copyright. Fees may apply:
| Type of Use | First Language Version (Per Project) | Additional Language Versions (Per Project) |
|---|---|---|
| Non-funded academic research | No charge | No charge |
| Individual clinical practice | No charge | No charge |
| Funded academic research | $300 | $150 |
| Commercial research | $2,000 | $1,200 |
The MDASI-RCC will be e-mailed to you as a PDF file within 7 to 10 business days. If your request is urgent or the language version you seek is not shown, contact us to make special arrangements:
Department of Symptom Research
Attn: Assessment Tools
The University of Texas MD Anderson Cancer Center
1515 Holcombe Boulevard, Unit 1450
Houston, Texas 77030
symptomresearch@mdanderson.org
If applicable, an invoice will be e-mailed to you. Reference the invoice number on your payment and include on the memo line, "MD Anderson Assessment Tool Distribution."
Notice of Copyright
The MD Anderson Symptom Inventory (MDASI) copyright is held by The University of Texas MD Anderson Cancer Center and administered by the MDASI's developer, Charles S. Cleeland, PhD. The copyright applies to the MDASI, its modules, and all its derivatives in any language.
The MDASI-RCC may not be used or reproduced without permission from Charles S. Cleeland, PhD, or his designee. Fees for use may apply (see above).
The MDASI and its modules may not be modified or translated into another language without the express written consent of the copyright holder. Failure to comply may result in legal action. Contact us via e-mail at symptomresearch@mdanderson.org or at the address shown above to obtain permission to alter or translate the instrument.